$ENDV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDONOVO THERAPEUTICS, INC.. Get notifications about new insider transactions in ENDONOVO THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 35 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 11,100 | 105 | 23,475,597 | 23.5 M to 23.5 M (+0.05 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 11,100 | 105 | 23,464,497 | 23.5 M to 23.5 M (+0.05 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 22,200 | 211 | 23,453,397 | 23.4 M to 23.5 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,600 | 53 | 23,431,197 | 23.4 M to 23.4 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,000 | 10 | 23,425,597 | 23.4 M to 23.4 M (0.00 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 190 | 23,424,597 | 23.4 M to 23.4 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 192 | 23,404,597 | 23.4 M to 23.4 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 98 | 23,384,597 | 23.4 M to 23.4 M (+0.04 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 23,374,597 | 23.4 M to 23.4 M (+0.04 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 188 | 23,364,597 | 23.3 M to 23.4 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,200 | 190 | 23,344,597 | 23.3 M to 23.3 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 29,800 | 283 | 23,324,397 | 23.3 M to 23.3 M (+0.13 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 200 | 23,294,597 | 23.3 M to 23.3 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 200 | 2 | 23,274,597 | 23.3 M to 23.3 M (0.00 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 198 | 23,274,397 | 23.3 M to 23.3 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50,000 | 500 | 23,254,397 | 23.2 M to 23.3 M (+0.22 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 192 | 23,204,397 | 23.2 M to 23.2 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 196 | 23,184,397 | 23.2 M to 23.2 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 200 | 23,164,397 | 23.1 M to 23.2 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 204 | 23,144,397 | 23.1 M to 23.1 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 202 | 23,124,397 | 23.1 M to 23.1 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 198 | 23,104,397 | 23.1 M to 23.1 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 96 | 23,084,397 | 23.1 M to 23.1 M (+0.04 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 23,074,397 | 23.1 M to 23.1 M (+0.04 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 40,000 | 400 | 23,064,397 | 23 M to 23.1 M (+0.17 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 23,024,397 | 23 M to 23 M (+0.04 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 49 | 23,014,397 | 23 M to 23 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 23,009,397 | 23 M to 23 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 23,004,397 | 23 M to 23 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 22,999,397 | 23 M to 23 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 22,994,397 | 23 M to 23 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 224 | 22,989,397 | 23 M to 23 M (+0.09 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 56 | 22,969,397 | 23 M to 23 M (+0.02 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 22,964,397 | 23 M to 23 M (+0.01 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 104 | 22,962,397 | 23 M to 23 M (+0.04 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 25,000 | 260 | 22,952,397 | 22.9 M to 23 M (+0.11 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 22,927,397 | 22.9 M to 22.9 M (+0.01 %) |
May 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 22,925,397 | 22.9 M to 22.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 21,877,397 | 21.9 M to 21.9 M (+0.01 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 21,877,397 | 21.9 M to 21.9 M (+0.01 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 21,875,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 21,875,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,870,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,870,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,865,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,865,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 21,860,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 21,860,397 | 21.9 M to 21.9 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 110 | 21,855,397 | 21.8 M to 21.9 M (+0.05 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 110 | 21,855,397 | 21.8 M to 21.9 M (+0.05 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,845,397 | 21.8 M to 21.8 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,845,397 | 21.8 M to 21.8 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,000 | 11 | 21,840,397 | 21.8 M to 21.8 M (0.00 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,000 | 11 | 21,840,397 | 21.8 M to 21.8 M (0.00 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,839,397 | 21.8 M to 21.8 M (+0.02 %) |
May 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,839,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 25 | 21,834,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,832,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 60 | 21,830,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 60 | 21,825,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 57 | 21,820,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,815,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 64 | 21,810,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 67 | 21,805,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 70 | 21,800,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 75 | 21,795,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,790,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 67 | 21,788,397 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 27 | 21,783,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 27 | 21,781,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 27 | 21,779,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,000 | 13 | 21,777,397 | 21.8 M to 21.8 M (0.00 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 179 | 21,776,397 | 21.8 M to 21.8 M (+0.07 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,500 | 22 | 21,761,397 | 21.8 M to 21.8 M (+0.01 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 4,900 | 61 | 21,759,897 | 21.8 M to 21.8 M (+0.02 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50 | 1 | 21,754,997 | 21.8 M to 21.8 M (0.00 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50 | 1 | 21,754,947 | 21.8 M to 21.8 M (0.00 %) |
May 17 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 25 | 21,754,897 | 21.8 M to 21.8 M (+0.01 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 72 | 21,752,897 | 21.7 M to 21.8 M (+0.02 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 67 | 21,747,897 | 21.7 M to 21.7 M (+0.02 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,742,897 | 21.7 M to 21.7 M (+0.01 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 115 | 21,740,897 | 21.7 M to 21.7 M (+0.05 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,730,897 | 21.7 M to 21.7 M (+0.02 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50,000 | 585 | 21,725,897 | 21.7 M to 21.7 M (+0.23 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,675,897 | 21.7 M to 21.7 M (+0.02 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 774 | 9 | 21,670,897 | 21.7 M to 21.7 M (0.00 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 21,670,123 | 21.7 M to 21.7 M (+0.01 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,668,123 | 21.7 M to 21.7 M (+0.02 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,663,123 | 21.7 M to 21.7 M (+0.02 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,658,123 | 21.7 M to 21.7 M (+0.01 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,656,123 | 21.7 M to 21.7 M (+0.01 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,654,123 | 21.7 M to 21.7 M (+0.01 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 238 | 21,652,123 | 21.6 M to 21.7 M (+0.09 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 116 | 21,632,123 | 21.6 M to 21.6 M (+0.05 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 115 | 21,622,123 | 21.6 M to 21.6 M (+0.05 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 120 | 21,612,123 | 21.6 M to 21.6 M (+0.05 %) |
May 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 124 | 21,602,123 | 21.6 M to 21.6 M (+0.05 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,592,123 | 21.6 M to 21.6 M (+0.01 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 60 | 21,590,123 | 21.6 M to 21.6 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 60 | 21,585,123 | 21.6 M to 21.6 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,580,123 | 21.6 M to 21.6 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 60 | 21,575,123 | 21.6 M to 21.6 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 61 | 21,570,123 | 21.6 M to 21.6 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 218 | 21,565,123 | 21.5 M to 21.6 M (+0.09 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,545,123 | 21.5 M to 21.5 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 23,096 | 252 | 21,540,123 | 21.5 M to 21.5 M (+0.11 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,904 | 21 | 21,517,027 | 21.5 M to 21.5 M (+0.01 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 21,515,123 | 21.5 M to 21.5 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,510,123 | 21.5 M to 21.5 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,505,123 | 21.5 M to 21.5 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 21,500,123 | 21.5 M to 21.5 M (+0.01 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 18,000 | 198 | 21,498,123 | 21.5 M to 21.5 M (+0.08 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 109 | 21,480,123 | 21.5 M to 21.5 M (+0.05 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 24,800 | 273 | 21,470,123 | 21.4 M to 21.5 M (+0.12 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 3,200 | 35 | 21,445,323 | 21.4 M to 21.4 M (+0.01 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 57 | 21,442,123 | 21.4 M to 21.4 M (+0.02 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 66,263 | 762 | 21,437,123 | 21.4 M to 21.4 M (+0.31 %) |
May 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 33,737 | 371 | 21,370,860 | 21.3 M to 21.4 M (+0.16 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 109 | 21,337,123 | 21.3 M to 21.3 M (+0.05 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 109 | 21,327,123 | 21.3 M to 21.3 M (+0.05 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,317,123 | 21.3 M to 21.3 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,312,123 | 21.3 M to 21.3 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,307,123 | 21.3 M to 21.3 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 21,302,123 | 21.3 M to 21.3 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 21,300,123 | 21.3 M to 21.3 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 216 | 21,295,123 | 21.3 M to 21.3 M (+0.09 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 21,275,123 | 21.3 M to 21.3 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 110 | 21,270,123 | 21.3 M to 21.3 M (+0.05 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,260,123 | 21.3 M to 21.3 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 18,000 | 198 | 21,255,123 | 21.2 M to 21.3 M (+0.08 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,237,123 | 21.2 M to 21.2 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,232,123 | 21.2 M to 21.2 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 21,227,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,225,123 | 21.2 M to 21.2 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 110 | 21,220,123 | 21.2 M to 21.2 M (+0.05 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 110 | 21,210,123 | 21.2 M to 21.2 M (+0.05 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 110 | 21,200,123 | 21.2 M to 21.2 M (+0.05 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 21,190,123 | 21.2 M to 21.2 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 3,150 | 35 | 21,185,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,850 | 20 | 21,181,973 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,180,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,178,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,176,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,174,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,172,123 | 21.2 M to 21.2 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 57 | 21,167,123 | 21.2 M to 21.2 M (+0.02 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,162,123 | 21.2 M to 21.2 M (+0.01 %) |
May 07 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,160,123 | 21.2 M to 21.2 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 30 | 21,158,123 | 21.2 M to 21.2 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 32 | 21,156,123 | 21.2 M to 21.2 M (+0.01 %) |